China's Top Departments: Gynecologic Oncology at the Obstetrics & Gynecology Hospital of Fudan University (Shanghai)

If you or a loved one is facing cervical, endometrial, ovarian or vulvar cancer, gestational trophoblastic neoplasia, or a recurrent gynecologic tumor — or if you are a young woman who hopes to preserve fertility while receiving cancer treatment — the Department of Gynecologic Oncology at the Obstetrics & Gynecology Hospital of Fudan University, affectionately known as the "Red House Hospital," is one of China's leading destinations, combining exceptional surgical volume with comprehensive, standardized cancer care.

About the Hospital

The Obstetrics & Gynecology Hospital of Fudan University, also known as the Shanghai Red House Hospital, was the first specialized obstetrics and gynecology hospital in China and the first institution in Shanghai to apply laparoscopy and hysteroscopy in gynecologic practice. Its predecessor, the "West Gate Women and Children's Hospital," was founded in 1884; it was rated a Grade 3A (tertiary, top-tier) hospital in 1995 and adopted its current name in 2002. Today it is a Grade 3A specialized teaching hospital integrating clinical care, teaching and research. Professor Wang Shuzhen, a former president of the hospital, was one of the founders of obstetrics and gynecology in China.

Campus addresses

• Huangpu Campus: No. 419 Fangxie Road (inpatient building), No. 566 Fangxie Road (outpatient building), No. 358 Dalin Road (maternity building)
• Yangpu Campus: No. 128 Shenyang Road, Yangpu District

Department Positioning

The Department of Gynecologic Oncology was established on the foundation of the hospital's long-established Department of Gynecology. It centers on integrated, standardized outpatient-to-inpatient care for gynecologic tumors and related research. As a key subspecialty of the hospital, it has built a routine, standardized and sustainable prevention-and-treatment framework tailored to different tumor types.

Team Strength

• 181 beds and 16 clinical teams
• 16 chief physicians and 11 associate chief physicians
• 10 doctoral supervisors and 8 master's supervisors
• Over 30 surgeons qualified for Grade 4 (highest-complexity) endoscopic gynecologic-oncology surgery — the highest number in Shanghai
• Department leadership: Director Ding Jingxin; Deputy Directors Jiang Wei and Wu Xin

Clinical Scale

• More than 8,000 surgeries per year, with Grade 4 procedures accounting for 50%
• Average annual admissions over the past 5 years:
  • Cervical cancer: over 3,000 cases
  • Endometrial cancer: over 1,000 cases
  • Ovarian cancer: nearly 400 cases
  • Gestational trophoblastic neoplasia: over 100 cases
• For cervical cancer, endometrial cancer and gestational trophoblastic neoplasia, case volumes rank first among hospitals in Shanghai and among the highest nationwide

Core Strengths and Signature Techniques

1. Disease-specific clinical groups Dedicated groups for ovarian cancer, endometrial cancer, cervical cancer and gestational trophoblastic neoplasia deliver comprehensive, integrated care across gynecologic tumors.

2. Fertility-preserving treatment For young patients with gynecologic tumors, the department offers fertility-preserving surgery and medical therapy for early-stage endometrial cancer, cervical cancer, ovarian tumors and gestational trophoblastic neoplasia — balancing cancer treatment with reproductive needs.

3. Minimally invasive surgery Minimally invasive approaches for early-stage gynecologic tumors include robotic surgery, 3D laparoscopic surgery and single-port laparoscopic surgery.

4. Standardized radical and staging surgery The department performs radical hysterectomy for cervical cancer, staging surgery for endometrial cancer, radical surgery for vulvar and vaginal cancer, and staging or tumor-debulking surgery for ovarian cancer.

5. Multidisciplinary surgery for advanced and recurrent tumors For advanced and recurrent tumors, multidisciplinary combined surgery is offered, including pelvic exenteration and secondary/multiple tumor debulking.

6. Comprehensive treatment and genetic counseling Chemotherapy, targeted therapy and other modalities are used for standardized, effective adjuvant treatment of post-operative and recurrent cases, with particular expertise in high-risk gestational trophoblastic neoplasia and drug-sensitivity screening and treatment for recurrent ovarian cancer. The department also provides genetic counseling for ovarian, endometrial and other gynecologic tumors.

7. Leadership in quality-control standards In 2019, Professor Hua Keqin of the gynecologic oncology department led the development of the first batch of Yangtze River Delta Quality-Control Standards for Single Gynecologic Diseases, covering the three major gynecologic malignancies (cervical, ovarian and endometrial cancer), and contributed to the national quality-control standards for cervical cancer. The Red House oncology quality-control standards reach across the Yangtze River Delta and nationwide.

Teaching and Research

• Undertakes more than 20 national and provincial/ministerial-level major projects, including National Key R&D Program projects, Fudan University Double First-Class discipline construction, Shanghai Municipal Health Commission paramount-priority projects and National Natural Science Foundation grants
• 116 funded projects in total (including 71 clinical research projects), with RMB 84.362 million in funding; 9 international multicenter studies and 37 domestic multicenter studies
• In 2021 the Clinical Research Center was officially inaugurated and a Phase I clinical trial ward opened; in 2022 the department was approved to build a "demonstration research-oriented ward"
• Over the past 5 years, 268 SCI papers on gynecologic oncology were published with a cumulative impact factor of 941.85; 78 papers with IF > 5, published in internationally renowned journals such as NEJM and Nature Communications
• Led or participated in 22 gynecologic-oncology guidelines/consensus statements; obtained 13 national patents (including 10 invention patents)
• Multiple faculty members have received the National Science and Technology Progress Award (Second Class), the Ministry of Education Natural Science Award (First Class) and the Shanghai Medical Science and Technology Award

If this department interests you, you may also want to read about gynecology at the Red House and oncology at Fudan University Shanghai Cancer Center.

This guide is compiled from the hospital's official website and other authoritative public sources.